• No results found

<p>Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas</p>

N/A
N/A
Protected

Academic year: 2020

Share "<p>Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas</p>"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 IdentiActin positive staining (100) (under bright-fication of human uterine leiomyoma cells and infection with IGF-1 lentivirus vectors
Figure 3 The protein expression of IGF-1 overexpression or knockdown and IGF-1 siRNA on human uterine leiomyoma cell viability
Figure 4 Effects of IGF-1 overexpression on cell viability with or without mifepristone
Figure 6 The flow diagram of the effect of mifepristone on signaling pathwaysrelated to IGF-1 in uterine leiomyoma cells.

References

Related documents

Deagle 46 identified the need for cross-cultural understanding and openness to nonverbal issues and the value of physicians’ participating in non- medical First

konnten hingegen in einer logistischen Regressions- analyse bei Kindern unter 1250 g zeigen, dass diese nach vaginaler Geburt ein elf Mal höhe- res Risiko besaßen, eine PVL zu

Abstract—A method based on adaptive neuro-fuzzy inference system (ANFIS) for computing the effective permittivity and the characteristic impedance of the micro-coplanar strip (MCS)

marianum as a function of (a) ethanol concentration and ultrasound frequency, (b)

temples and churches , they will give thanks to our Gracious Lord for the blessing of independence. But at the same time, countless tens of thousands of fellow Indonesians

In doing so, we build and investigate the trading ability of five mechanical trading systems: 1 traditional fundamental analysis; 2 corporate governance analysis; 3 technical

With the biased open duty cycle, flow rate was relatively constant with increas- ing cut rate once a maximum flow rate had been achieved; however, the cut rate at which maximum

The purpose of this study was to evaluate the efficacy of postoperative patient instruction on the proficiency of eye drop instillation following cataract surgery, and